Current price is less than the intrinsic value

Intrinsic Value

Stock has been generating better return on equity than bank FD

ROE vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Glenmark is the first company in India to market the innovative FDC of Teneligliptin + Pioglitazone, which is approved by the DCGI (Drug Controller General of India).

Glenmark launches Teneligliptin + Pioglitazone Fixed-Dose Combination Drug

Glenmark Pharmaceuticals on Monday said it has launched a novel fixed-dose combination (FDC) of Teneligliptin, with Pioglitazone in India for adults.

Glenmark launches fixed-dose combination medication for diabetic patients

Glenmark has launched this FDC under the brand name Zita Plus Pio, which contains Teneligliptin (20 mg) and Pioglitazone (15 mg), to be taken once a day, the company said in a statement.

Glenmark launches fixed-dose combination for diabetic patients

The drug maker has launched a novel fixed-dose combination (FDC) of a widely used DPP4 inhibitor (Dipeptidyl Peptidase 4 inhibitor), Teneligliptin, with Pioglitazone for type 2 diabetes in India.

Glenmark Pharma launches FDC for type 2 diabetes in India

FDC chairman Vanteru Pratap Reddy was also in the list

Land oustees receive summons in police cases

FDC Consolidated December 2021 Net Sales at Rs 341.78 crore, up 0.46% Y-o-Y

FDC rallied 6.04% to Rs 312.35 after the board decided to meet on 9 February 2022, to consider financial results for the quarter & nine months ended 31 December 2021 and proposal for buyback of fully paid up equity shares through tender offer route.

FDC spurts after board plans to consider buyback proposal on Feb. 9

The company’s board will meet on February 9, 2022 to consider the proposal for buyback of equity shares of the company through tender offer route.

FDC surges 8% as board to consider share buyback proposal

Here are the stocks to watch in trade today..

Stocks To Watch: PTC India, Birla Corp, ONGC, Inox Leisure, FDC

Zensar Technologies Ltd, Aurum Proptech Ltd, Time Technoplast Ltd and FDC Ltd are among the other losers in the BSE’s ‘A’ group today, 18 November 2021.

Vedanta Ltd leads losers in ‘A’ group

FDC Q2 Review - Strong Domestic Recovery: Centrum Broking

FDC Limited is a pharmaceutical company  engaged in manufacture of specialized formulations, and oral rehydration salts (ORS). Its brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.

F D C Ltd

F D C Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Glenmark launches Teneligliptin + Pioglitazone Fixed-Dose Combination Drug

Glenmark launches fixed-dose combination medication for diabetic patients

Glenmark launches fixed-dose combination for diabetic patients

Glenmark Pharma launches FDC for type 2 diabetes in India

Land oustees receive summons in police cases

FDC Consolidated December 2021 Net Sales at Rs 341.78 crore, up 0.46% Y-o-Y

FDC spurts after board plans to consider buyback proposal on Feb. 9

F D C Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Glenmark launches Teneligliptin + Pioglitazone Fixed-Dose Combination Drug

Glenmark launches fixed-dose combination medication for diabetic patients

Glenmark launches fixed-dose combination for diabetic patients

Glenmark Pharma launches FDC for type 2 diabetes in India

Land oustees receive summons in police cases

FDC Consolidated December 2021 Net Sales at Rs 341.78 crore, up 0.46% Y-o-Y

FDC spurts after board plans to consider buyback proposal on Feb. 9

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock